or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 25 Pharmacy PhD Projects, Programmes & Scholarships for Self-funded Students in Bradford
Pharmacy PhD Projects, Programmes & Scholarships for Self-funded Students in Bradford
We have 25 Pharmacy PhD Projects, Programmes & Scholarships for Self-funded Students in Bradford
New Drugs for Brain Tumours: Prodrugs of Diazopropyne
Research Group:
Medicines Development and Pharmaceutical Sciences
The propargyl group, introduced to temozolomide-like drugs for brain tumours by our colleagues in Nottingham, shows considerable pre-clinical promise and… Read more
New Drugs for Brain Tumours: Defining the Physicochemical Parameters for Optimal Imidazotetrazine (Temozolomide) Derivative Prodrug Activation Kinetics
Research Group:
Medicines Development and Pharmaceutical Sciences
The imidazotetrazine ring system that forms the core of the anticancer drug temozolomide is a fascinating prodrug delivery device. Read more
New Drugs for Brain Tumours: A Locoregional Implant Brain Tumours
Research Group:
Medicines Development and Pharmaceutical Sciences
Next-generation temozolomide derivatives for the treatment of high-grade glioma have been developed at the University of Bradford. Read more
ERK5 MAPK signalling in Alzheimer’s disease
Research Group:
Pharmacology and Experimental Therapeutics
Neurodegenerative diseases have devastating effects on individuals’ lives and our society, with no effective treatments available. Read more
Formulation and biopharmaceutical characterisation of novel pro-antibiotics for improved oral permeability
Research Group:
Pharmacology and Experimental Therapeutics
This project is focused on the formulation, synthesis, and biopharmaceutical characterisation of novel pro-antibiotics for improved oral bioavailability. . Read more
Reviewing and optimising the use of electronic prescribing systems to improve medicine safety in integrated care systems
Research Group:
Health Technologies
With a rapidly ageing population in the UK, there is an escalating demand for older care that requires therapeutic drug monitoring with the help of electronic prescribing and record systems (EPRS). Read more
Formulation of heterogenous solid dispersions produced by spray drying and hot-melt extrusion for improved delivery of amorphous drugs
Research Group:
Pharmacology and Experimental Therapeutics
Production of the amorphous solid dispersions (ASDs) is a one of the methods of improving of physicochemical properties of an active pharmaceutical ingredient (API) such as its solubility and physicochemical stability. Read more
Cellular signalling mechanisms in iPSC-derived cardiovascular cells
Research Group:
Pharmacology and Experimental Therapeutics
Induced pluripotent stem cells (iPSCs) offer an advanced platform for disease modelling, drug discovery, and regenerative therapies. Read more
MAPK signalling pathways regulating the blood brain barrier
Research Group:
Pharmacology and Experimental Therapeutics
We invite applications for a 3-year PhD project to investigate cellular signalling regulating the function of the blood brain barrier. Read more
Targeting the MAPK scaffold protein KSR1 for the treatment of prostate cancer
Research Group:
Institute of Cancer Therapeutics
Prostate cancer is one of the leading causes of male cancer deaths. It arises when individual cells escape their normal growth control mechanisms and proliferate in an uncontrolled fashion. Read more
Pharmacokinetics Guided Natural Products Exploration for Drug Discovery, Development, Delivery and Therapy
Research Group:
Institute of Cancer Therapeutics
Natural products have emerged as a key standard in novel and safe delivery of anticancer bioactive compounds. Apart from their ease of administration and delivery, natural/phytochemicals still face several hurdles, due to their physiochemical and pharmacokinetic properties. Read more
Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products
Research Group:
Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more
Therapeutic resolution of Myelodysplastic Syndrome (MDS) by natural products
Research Group:
Pharmacology and Experimental Therapeutics
Myelodysplastic syndromes (MDS) are a type of blood cancer where the patients do not have enough healthy blood cells. Read more
Therapeutic resolution of coronavirus (COVID-19) diseases by natural products
Research Group:
Pharmacology and Experimental Therapeutics
Coronavirus now labelled as Covid-19 has become a global pandemic affecting around 200 countries. Currently neither any cure nor any vaccine for Covid-19 has been established. Read more
Development of a personalized therapy for pulmonary arterial hypertension (PAH)
Research Group:
Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more
- 1
- 2